生物
生殖系
遗传学
计算生物学
基因组
基因
错义突变
损失函数
基因组编辑
种系突变
编码
表型
突变
作者
Gregory M. Findlay,Riza M. Daza,Beth Martin,Melissa D. Zhang,Anh Leith,Molly Gasperini,Joseph D. Janizek,Xingfan Huang,Lea M. Starita,Jay Shendure
出处
期刊:Nature
[Springer Nature]
日期:2018-09-12
卷期号:562 (7726): 217-222
被引量:576
标识
DOI:10.1038/s41586-018-0461-z
摘要
Variants of uncertain significance fundamentally limit the clinical utility of genetic information. The challenge they pose is epitomized by BRCA1, a tumour suppressor gene in which germline loss-of-function variants predispose women to breast and ovarian cancer. Although BRCA1 has been sequenced in millions of women, the risk associated with most newly observed variants cannot be definitively assigned. Here we use saturation genome editing to assay 96.5% of all possible single-nucleotide variants (SNVs) in 13 exons that encode functionally critical domains of BRCA1. Functional effects for nearly 4,000 SNVs are bimodally distributed and almost perfectly concordant with established assessments of pathogenicity. Over 400 non-functional missense SNVs are identified, as well as around 300 SNVs that disrupt expression. We predict that these results will be immediately useful for the clinical interpretation of BRCA1 variants, and that this approach can be extended to overcome the challenge of variants of uncertain significance in additional clinically actionable genes. Germline BRCA1 loss-of-function variants are associated with predisposition to early-onset breast and ovarian cancer; here the authors use CRISPR/Cas9 genome editing to functionally assess thousands of BRCA1 variants in order to facilitate the clinical interpretation of these variants.
科研通智能强力驱动
Strongly Powered by AbleSci AI